📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: PacBio

1.1 - Company Overview

PacBio Logo

PacBio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of sequencing systems and technologies for genomic, epigenomic, and transcriptomic analysis, including Revio long-read sequencing, Onso short-read with Sequencing by Binding (SBB) for high accuracy, rare variant detection and difficult-region analysis, Sequel IIe for HiFi reads in whole-genome and RNA sequencing, HiFi sequencing, and Kinnex kits for high-throughput RNA workflows (full-length, single-cell, 16S rRNA).

Products and services

  • HiFi sequencing: High-accuracy technology that combines extended read lengths with precision to enable comprehensive variant detection and robust genome assembly across complex genomic regions
  • Revio system: Long-read sequencing system that delivers high throughput and accuracy for genome, epigenome, and transcriptome analysis, enabling high-quality sequencing for integrated DNA, RNA, and epigenetic investigations
  • Onso system: Short-read platform that delivers high accuracy and sensitivity using Sequencing by Binding (SBB) to detect rare variants and analyze difficult genomic regions with superior accuracy over traditional methods

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to PacBio

Remedy Plan Logo

Remedy Plan

HQ: United States Website
  • Description: Provider of pre-clinical cancer therapeutics developing first-in-class small molecule drugs that differentiate cancer cells, including RPT1G, a clinical candidate targeting NAMPT for solid and hematological malignancies. Offers NAMPT programs in oncology, autoimmune, and obesity, and a proprietary high-throughput phenotypic drug screening platform targeting critical pathways in cancer stem cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Remedy Plan company profile →
BD Biosciences Logo

BD Biosciences

HQ: United States Website
  • Description: Provider of flow cytometers; research cell analyzers and cell sorters; clinical cell analyzers; single-cell multiomics systems; and automated sample preparation systems for flow cytometry, supporting applications in immunology, cancer research, diagnostics, and clinical research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BD Biosciences company profile →
GlycoFi Logo

GlycoFi

HQ: United States Website
  • Description: Provider of biotherapeutic development based on glycan optimization technology and a yeast-based glycosylation protein manufacturing process, aiming to build its own pipeline of therapeutic proteins and partner with other drug-makers to develop products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GlycoFi company profile →
BlinkBio Logo

BlinkBio

HQ: United States Website
  • Description: Provider of specialized bioorthogonal chemistries for the delivery of next-generation medicines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BlinkBio company profile →
Applied Molecular Transport Logo

Applied Molecular Transport

HQ: United States Website
  • Description: Provider of novel oral biological therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Applied Molecular Transport company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for PacBio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to PacBio

2.2 - Growth funds investing in similar companies to PacBio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for PacBio

4.2 - Public trading comparable groups for PacBio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to PacBio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About PacBio

What does PacBio do?

PacBio is a provider of sequencing systems and technologies for genomic, epigenomic, and transcriptomic analysis, including Revio long-read sequencing, Onso short-read with Sequencing by Binding (SBB) for high accuracy, rare variant detection and difficult-region analysis, Sequel IIe for HiFi reads in whole-genome and RNA sequencing, HiFi sequencing, and Kinnex kits for high-throughput RNA workflows (full-length, single-cell, 16S rRNA).

Who are PacBio's competitors?

PacBio's competitors and similar companies include Remedy Plan, BD Biosciences, GlycoFi, BlinkBio, and Applied Molecular Transport.

Where is PacBio headquartered?

PacBio is headquartered in United States.

How many employees does PacBio have?

PacBio has 1,000 employees 🔒.

When was PacBio founded?

PacBio was founded in 2010 🔒.

What sector and industry vertical is PacBio in?

PacBio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for PacBio

Who are the top strategic acquirers in PacBio's sector and industry

Top strategic M&A buyers and acquirers in PacBio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for PacBio?

Top strategic M&A buyers groups and sectors for PacBio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in PacBio's sector and industry vertical

Which are the top PE firms investing in PacBio's sector and industry vertical?

Top PE firms investing in PacBio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in PacBio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in PacBio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in PacBio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to PacBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in PacBio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for PacBio?

The key public trading comparables and valuation benchmarks for PacBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for PacBio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for PacBio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in PacBio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for PacBio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in PacBio's' sector and industry vertical?

Access recent funding rounds and capital raises in PacBio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for PacBio